UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

311: A CXCR4-positive subpopulation exhibits cancer stem cell properties in renal cell carcinoma

European journal of cancer (1990), 2014-07, Vol.50, p.S74-S74

2014

Volltextzugriff (PDF)

Lysis of Prostate Carcinoma Cells by Trifunctional Bispecific Antibodies ({{alpha}}EpCAM {{alpha}}CD3)

The journal of histochemistry and cytochemistry, 2001-07, Vol.49 (7), p.911-917

2001

Volltextzugriff (PDF)

Allogeneic gene-modified tumor cells (RCC-26 IL-7 CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

Gene therapy, 2011-04, Vol.18 (4), p.354-363

2011

Volltextzugriff (PDF)

Allogeneic retrovirally transduced, IL-2- and IFN-γ-secreting cancer cell vaccine in patients with hormone refractory prostate cancer-a phase I clinical trial

The journal of gene medicine, 2007-07, Vol.9 (7), p.547-560

2007

Volltextzugriff (PDF)

IMMUNOMAGNETIC CELL ENRICHMENT DETECTS MORE DISSEMINATED CANCER CELLS THAN IMMUNOCYTOCHEMISTRY IN VITRO

The Journal of urology, 2000-11, Vol.164 (5), p.1834-1837

2000

Volltextzugriff (PDF)

Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma

Clinical cancer research, 2006-02, Vol.12 (3), p.718-725

2006

Volltextzugriff (PDF)

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

Gene therapy, 2000-12, Vol.7 (23), p.2007-2014

2000

Volltextzugriff (PDF)

Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes

International journal of cancer, 2003-10, Vol.106 (6), p.905-912

2003

Volltextzugriff (PDF)

Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay

Nature medicine, 2001-10, Vol.7 (10), p.1159-1162

2001

Volltextzugriff (PDF)

Isolation of Circulating Cancer Cells From Whole Blood By Immunomagnetic Cell Enrichment and Unenriched Immunocytochemistry In Vitro

The Journal of urology, 2003-02, Vol.169 (2), p.701-705

2003

Volltextzugriff (PDF)

Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma

Human gene therapy, 2010-03, Vol.21 (3), p.285

2010

Volltextzugriff (PDF)

RNA Transfer by Electroporation into Mature Dendritic Cells Leading to Reactivation of Effector-Memory Cytotoxic T Lymphocytes: A Quantitative Analysis

Molecular therapy, 2005-10, Vol.12 (4), p.734-743

2005

Volltextzugriff (PDF)

Allogeneic vaccination for renal cell carcinoma: development and monitoring

Bone marrow transplantation (Basingstoke), 2000-05, Vol.25 Suppl 2 (S2), p.S83-S87

2000

Volltextzugriff (PDF)

HSP expression in human leukocytes is modulated by endurance exercise

Medicine and science in sports and exercise, 2000-03, Vol.32 (3), p.592-600

2000

Volltextzugriff (PDF)

Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs

Clinical cancer research, 2005-03, Vol.11 (5), p.1733-1742

2005

Volltextzugriff (PDF)

Cancer gene therapy with a retrovirally transduced IL2-IFNγ-secreting allogeneic tumorvaccine in patients with progressive hormone refractory prostate cancer—A phase I/II trial

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.5127-5127

2007

Volltextzugriff (PDF)

Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells

World journal of urology, 2005-07, Vol.23 (3), p.166-174

2005

Volltextzugriff (PDF)

HLA-A0201-positive, IL-7/B7.1-cotransfected allogeneic tumor cells as a vaccine in metastatic renal cell cancer—A clinical phase-I trial

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.3072-3072

2007

Volltextzugriff (PDF)

Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: Preclinical evaluation

Clinical cancer research, 2003-09, Vol.9 (11), p.4240-4246

2003

Volltextzugriff (PDF)

49 THERAPEUTIC VACCINATION IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE CANCER - RESULTS OF AN OPEN-LABELED PHASE I/II TRIAL WITH AN IL2-IFN-Y SECRETING ALLOGENEIC TUMORVACCINE

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.133-133

2009

Volltextzugriff (PDF)

A phase I/II trial of an allogeneic IL2-IFNγ-secreting tumor vaccine in patients with hormone refractory prostate cancer (HRPC)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4748-4748

2005

Volltextzugriff (PDF)

Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?

Mechanisms of ageing and development, 1995-09, Vol.83 (3), p.171-183

1995

Volltextzugriff (PDF)

Extrathymic Development and Function of Human T-Lymphocytes from Bone Marrow Cells in Vitro

Cellular immunology, 1994-03, Vol.154 (1), p.25-42

1994

Volltextzugriff (PDF)

Role of three quantitatively dominant endogenous peptides from HLA-DRB10401 molecules in class II specific alloreactivity

Transplant immunology, 1994-12, Vol.2 (4), p.293-299

1994

Volltextzugriff (PDF)

Gill surface area of water-breathing freshwater fish

Reviews in fish biology and fisheries, 1992-09, Vol.2 (3), p.187-216

1992

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(61)
Science & Technology
(58)
Life Sciences & Biomedicine
(56)
Biological And Medical Sciences
(31)
Male
(21)
Medical Sciences
(20)
Dermatology
(15)
Adult
(14)
Female
(14)
Fundamental And Applied Biological Sciences. Psychology
(14)
Immunology
(13)
Middle Aged
(13)
T-Lymphocytes - Immunology
(12)
Molecular Sequence Data
(11)
Aged
(9)
Cell Biology
(9)
Base Sequence
(8)
Biotechnology & Applied Microbiology
(8)
Bullous Diseases Of The Skin
(8)
Genetics & Heredity
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

311: A CXCR4-positive subpopulation exhibits cancer stem cell properties in renal cell carcinoma

Lysis of Prostate Carcinoma Cells by Trifunctional Bispecific Antibodies ({{alpha}}EpCAM {{alpha}}CD3)

Allogeneic gene-modified tumor cells (RCC-26 IL-7 CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

Allogeneic retrovirally transduced, IL-2- and IFN-γ-secreting cancer cell vaccine in patients with hormone refractory prostate cancer-a phase I clinical trial

IMMUNOMAGNETIC CELL ENRICHMENT DETECTS MORE DISSEMINATED CANCER CELLS THAN IMMUNOCYTOCHEMISTRY IN VITRO

Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma

Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse

Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes

Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay

Isolation of Circulating Cancer Cells From Whole Blood By Immunomagnetic Cell Enrichment and Unenriched Immunocytochemistry In Vitro

Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma

RNA Transfer by Electroporation into Mature Dendritic Cells Leading to Reactivation of Effector-Memory Cytotoxic T Lymphocytes: A Quantitative Analysis

Allogeneic vaccination for renal cell carcinoma: development and monitoring

HSP expression in human leukocytes is modulated by endurance exercise

Influence of CD80, Interleukin-2, and Interleukin-7 Expression in Human Renal Cell Carcinoma on the Expansion, Function, and Survival of Tumor-Specific CTLs

Cancer gene therapy with a retrovirally transduced IL2-IFNγ-secreting allogeneic tumorvaccine in patients with progressive hormone refractory prostate cancer—A phase I/II trial

Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells

HLA-A0201-positive, IL-7/B7.1-cotransfected allogeneic tumor cells as a vaccine in metastatic renal cell cancer—A clinical phase-I trial

Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: Preclinical evaluation

49 THERAPEUTIC VACCINATION IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE CANCER - RESULTS OF AN OPEN-LABELED PHASE I/II TRIAL WITH AN IL2-IFN-Y SECRETING ALLOGENEIC TUMORVACCINE

A phase I/II trial of an allogeneic IL2-IFNγ-secreting tumor vaccine in patients with hormone refractory prostate cancer (HRPC)

Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?

Extrathymic Development and Function of Human T-Lymphocytes from Bone Marrow Cells in Vitro

Role of three quantitatively dominant endogenous peptides from HLA-DRB10401 molecules in class II specific alloreactivity

Gill surface area of water-breathing freshwater fish

Suchergebnisse filtern